Rep. Nick LaLota introduced H.R. 9913, the Safe Sips Act, to create a common identifier for beverages containing THC, other intoxicating cannabinoids, alcohol, kratom-related compounds, or other intoxicants. Read the official bill record.

The proposal would place the selected color at the dispensing point and require an additional non-color identifier for accessibility. The bill has been referred to the House Energy and Commerce and Ways and Means committees. It is not law.

Do not rely on can shape, flavor, brand styling, or shelf placement to distinguish an intoxicating beverage. Read the entire label and confirm the active intoxicant and amount per serving and container.

Keep these drinks in original packaging, store them apart from ordinary beverages, and secure them from children, pets, and anyone who could mistake them for a nonintoxicating drink.

Ask specifically about beverages, which can be overlooked when a patient reports cannabis use. Document the product, intoxicant, milligrams per serving, number of servings consumed, timing, co-use with alcohol or sedating medications, and driving or work plans.

Counsel that delayed onset can encourage premature redosing. A future package marker would not make products pharmacologically equivalent.

The proposal tries to create a recognition layer across product categories that are now regulated under different legal frameworks. Its scope extends beyond cannabis beverages to alcohol, kratom-related compounds, and other intoxicants.

That breadth may improve consistency, but it also creates a design challenge because the covered drinks have different pharmacology, dose conventions, evidence bases, and risk profiles.

An introduced bill does not change current packaging requirements. Committee referral does not predict passage, final language, implementation dates, or agency design choices.

The proposal includes no outcome data showing fewer accidental ingestions, impaired-driving events, emergency visits, or poison-center calls.

THC beverage effects depend on dose, formulation, prior exposure, food intake, metabolism, co-use, and individual vulnerability. Alcohol, THC, and concentrated kratom-related compounds should not be treated as interchangeable because they share a marker.

Pregnancy, adolescence, older age, psychiatric or cardiovascular vulnerability, liver disease, substance-use risk, and interacting medicines may require additional caution. No intoxicating beverage should be used before driving or hazardous work.

The bill sponsor presents the marker as a child-safety and consumer-recognition measure. That is a policy rationale, not evidence that the selected system will work as intended.

A marker could create false reassurance if consumers skip the detailed label. Any final design should be tested for recognition, comprehension, color-vision accessibility, literacy, and performance in real retail and home settings.

The central policy question is whether a simple cross-category cue can improve recognition without obscuring product-specific information.

A strong implementation plan would preserve clear ingredient and dose disclosures, child-resistant packaging where appropriate, age controls, adverse-event surveillance, enforcement, and public education.

Cannabinoid beverages occupy a mixed federal and state landscape, while alcohol and cannabis products can have different labeling, retail, and enforcement systems.

A useful national identifier would still need consumer testing, accessibility review, enforcement, and coordination with ingredient lists, cannabinoid content, serving information, age restrictions, and warnings.

A clear visual cue is a reasonable safety concept because people often identify drinks by package shape and front-facing design before reading fine print.

Clinically, the marker would be only the first question. Patients still need to know what the intoxicant is, how much is present per serving and container, how quickly it may take effect, how long impairment may last, and whether other medications or health conditions increase risk.

Four distinctions that matter